Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
- Conditions
- ObesityOverweight
- Interventions
- Drug: Placebo (semaglutide)
- Registration Number
- NCT03574597
- Lead Sponsor
- Novo Nordisk A/S
- Brief Summary
The researchers are doing the study to see if semaglutide may reduce the risk of having cardiovascular events in patients with overweight or obesity and with prior cardiovascular disease. The participant will either get semaglutide (active medicine) or placebo ("dummy" medicine). Which treatment the participants get is decided by chance. The participant's chance of getting semaglutide or placebo is the same. The participant will get the study medicine in a pen. The participants will need to use the pen to inject the study medicine in a skinfold once a week. The study will last for about 2.5 to 5 years. Participants will have up to 25 clinic visits with the study doctor.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 17609
- Informed consent obtained before any trial-related activities. Trial-related activities are any procedures that are carried out as part of the trial, including activities to determine suitability for the trial
- Male or female, age greater than or equal to 45 years at the time of signing informed consent
- Body mass index (BMI) greater than or equal to 27 kg/m^2
- Have established cardiovascular (CV) disease as evidenced by at least one of the following: prior myocardial infarction; prior stroke (ischemic or haemorrhagic stroke); or symptomatic peripheral arterial disease (PAD), as evidenced by intermittent claudication with ankle-brachial index (ABI) less than 0.85 (at rest), or peripheral arterial revascularization procedure, or amputation due to atherosclerotic disease
Cardiovascular-related:
- Any of the following: myocardial infarction, stroke, hospitalisation for unstable angina pectoris or transient ischaemic attack within the past 60 days prior to the day of screening
- Planned coronary, carotid or peripheral artery revascularisation known on the day of screening
- Presently classified as being in New York Heart Association (NYHA) Class IV heart failure
Glycaemia-related:
- HbA1c greater than or equal to 48 mmol/mol (6.5 %) as measured by the central laboratory at screening
- History of type 1 or type 2 diabetes (history of gestational diabetes is allowed)
- Treatment with glucose-lowering agents within 90 days before screening
- Treatment with any glucagon-like-peptide-1 receptor agonist (GLP-1 RA) within 90 days before screening
General safety:
- History or presence of chronic pancreatitis
- Presence of acute pancreatitis within the past 180 days prior to the day of screening
- Personal or first degree relative(s) history of multiple endocrine neoplasia type 2 or medullary thyroid carcinoma
- End stage renal disease or chronic or intermittent haemodialysis or peritoneal dialysis
- Presence or history of malignant neoplasms within the past 5 years prior to the day of screening. Basal and squamous cell skin cancer and any carcinoma in-situ are allowed
- Severe psychiatric disorder which in the investigator's opinion could compromise compliance with the protocol
- Known or suspected hypersensitivity to trial products or related products
- Previous participation in this trial. Participation is defined as randomisation
- Receipt of any investigational medicinal product within 30 days before screening
- Female who is pregnant, breast-feeding or intends to become pregnant or is of child-bearing potential and not using a highly effective contraceptive method
- Any disorder, unwillingness or inability, which in the investigator's opinion, might jeopardise the participant's safety or compliance with the protocol
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo (semaglutide) Placebo (semaglutide) Participants will receive placebo (semaglutide) as an adjunct to standard-of-care. Estimated trial duration for an individual subject is from 31 to 59 months. Semaglutide Semaglutide Participants will receive semaglutide as an adjunct to standard-of-care. Estimated trial duration for an individual subject is from 31 to 59 months.
- Primary Outcome Measures
Name Time Method Participants From Time of Randomization to First Occurrence of a Composite Outcome Measure Consisting of: Cardiovascular (CV) Death, Non-fatal Myocardial Infarction (MI), or Non-fatal Stroke From randomisation (week 0) up to 240 weeks Number of participants with first occurrence of composite outcome measure consisted of CV death (undetermined cause of death presumed CV death), non-fatal MI, or non-fatal stroke are presented. The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
- Secondary Outcome Measures
Name Time Method Participants From Time of Randomisation to CV Death From randomisation (week 0) up to 240 weeks Number of participants with CV death are presented. The outcome measure was evalulated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Participants From Time of Randomisation to First Occurrence of a Composite Heart Failure (HF) Outcome Measure Consisting of: HF Hospitalisation, Urgent HF Visit or CV Death From randomisation (week 0) up to 240 weeks Number of participants with first occurrence of a composite HF outcome measure consisted of HF hospitalisation, urgent HF visit or CV death are presented. The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Participants From Time of Randomisation to All-cause Death From randomisation (week 0) up to 240 weeks Number of participants with all-cause death are presented. The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Participants From Time of Randomisation to First Occurrence of an Expanded Composite CV Outcome Measure Consisting of: CV Death, Non-fatal MI, Non-fatal Stroke, Coronary Revascularisation or Unstable Angina Pectoris (UAP) Requiring Hospitalisation From randomisation (week 0) up to 240 weeks Number of participants with first occurrence of an expanded composite CV outcome measure consisted of CV death, non-fatal MI, non-fatal stroke, coronary revascularisation or UAP requiring hospitalisation are presented. The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Participants From Time of Randomisation to First Occurrence of a Composite Outcome Measure Consisting of: All-cause Death, Non-fatal MI, or Non-fatal Stroke From randomisation (week 0) up to 240 weeks Number of participants with first occurrence of a composite outcome measure consisted of all-cause death, non-fatal MI, or non-fatal stroke are presented. The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Participants From Time of Randomisation to First Occurrence of Non-fatal MI From randomisation (week 0) up to 240 weeks Number of participants with first occurrence of non-fatal MI are presented. The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Participants From Time of Randomisation to First Occurrence of Non-fatal Stroke From randomisation (week 0) up to 240 weeks Number of participants with first occurrence of non-fatal stroke are presented. The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Participants From Time of Randomisation to First Occurrence of Coronary Revascularisation From randomisation (week 0) up to 240 weeks Number of participants with first occurrence of coronary revascularisation are presented. The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Participants From Time of Randomisation to First Occurrence of UAP Requiring Hospitalisation From randomisation (week 0) up to 240 weeks Number of participants with first occurrence of UAP requiring hospitalisation are presented. The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Participants From Time of Randomisation to First Occurrence of HF Requiring Hospitalisation or Urgent HF Visit From randomisation (week 0) up to 240 weeks Number of participants with first occurrence of HF requiring hospitalisation or urgent HF visit are presented. The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Participants From Time of Randomisation to First Occurrence of Glycosylated Haemoglobin (HbA1c) Greater Than Equals to (≥) 48 Millimole Per Mole (mmol/Mol) (6.5 Percentage [%]) From randomisation (week 0) up to 240 weeks Number of participants with first occurrence of HbA1c ≥ 48 mmol/mol (6.5%) are presented. The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Participants From Time of Randomisation to First Occurrence of a 5-component Composite Nephropathy Outcome Measure From randomisation (week 0) up to 240 weeks Number of participants with first occurrence of a 5-component composite nephropathy outcome measure consisted of onset of persistent macroalbuminuria (UACR \> 300 milligram per gram \[mg/g\]), persistent 50% reduction in estimated glomerular filtration rate (eGFR) compared with baseline (randomisation), onset of persistent eGFR \< 15 ml/min/1.73m\^2, initiation of chronic renal replacement therapy (dialysis or transplantation) or renal death. The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Participants From Time of Randomisation to HbA1c ≥ 39 mmol/Mol (5.7%) (for Participants With a Screening HbA1c <39 mmol/Mol [5.7%]) From randomisation (week 0) up to 240 weeks Number of participants with HbA1c ≥ 39 mmol/mol (5.7%) are presented. The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Participants With HbA1c < 39 mmol/Mol (5.7%) (for Participants With a Screening HbA1c ≥ 39 mmol/Mol [5.7%]) At week 52, week 104 Number of participants with HbA1c \< 39 mmol/mol (5.7%) are presented. The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Change in Systolic Blood Pressure (SBP) Week 0, week 104 Change in SBP from randomisation (week 0) to week 104 is presented. The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Change in Diastolic Blood Pressure (DBP) Week 0, week 104 Change in DBP from randomisation (week 0) to week 104 is presented. The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Change in Pulse Week 0, week 104 Change in pulse from randomisation (week 0) to week 104 is presented. The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Change in High Sensitivity C-Reactive Protein (hsCRP) - Ratio to Baseline Week 0, week 104 Change in hsCRP (milligram per liter \[mg/L\]) from randomisation (week 0) to week 104 presented as ratio to baseline (week 0). The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Change in Total Cholesterol - Ratio to Baseline Week 0, week 104 Change in total cholesterol (milligram per deciliter \[mg/dL\]) from randomisation (week 0) to week 104 is presented as ratio to baseline (week 0). The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Change in High Density Lipoprotein (HDL) Cholesterol - Ratio to Baseline Week 0, week 104 Change in HDL (mg/dL) from randomisation (week 0) to week 104 is presented as ratio to baseline (week 0). The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Change in Low Density Lipoprotein (LDL) Cholesterol - Ratio to Baseline Week 0, week 104 Change in LDL (mg/dL) from randomisation (week 0) to week 104 is presented as ratio to baseline (week 0). The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Change in Triglycerides - Ratio to Baseline Week 0, week 104 Change in triglycerides (mg/dL) from randomisation (week 0) to week 104 is presented as ratio to baseline (week 0). The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Change in Body Weight Week 0, week 104 Percentage change in body weight from randomisation (week 0) to week 104 is presented. The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Change in Waist Circumference Week 0, week 104 Change is waist circumference from randomisation (week 0) to week 104 is presented. The outcome measure was evaluated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Change From Randomisation (Week 0) in Participant Reported Outcome (PRO): EuroQol Five Dimensions Five Level Questionnaire (EQ-5D-5L) Index Score to Week 104 Week 0, week 104 EQ-5D-5L is a PRO tool used to estimate impact on participant's health-related quality of life and provides a description of their problems by dimensions (descriptive system). EQ-5D has 5 dimensions: mobility, self-care, usual activities, pain, anxiety/depression, and each dimension has 5 levels: not at all, mild, moderate, severe, extreme. Participant marks most appropriate statement in each dimension, resulting in 1-digit number and digits from 5 dimensions can be combined in 5-digit number describing participant's health state. Index score records an average health status according to dimensions using an algorithm, ranges 0-1 with higher score indicates better health status. Outcome measure was evaluated based on data from in-trial observation period (defined as date of randomisation to one of the dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant \[who were lost to follow-up\], date of death).
Change From Randomisation (Week 0) in PRO: EuroQol Five Dimensions Visual Analogue Scale (EQ-5D-VAS) to Week 104 Week 0, week 104 EQ-5D-5L is a PRO tool used to estimate impact on participant's health-related quality of life and provides a description of their problems by dimensions (descriptive system). EQ-5D has 5 dimensions: mobility, self-care, usual activities, pain, anxiety/depression, and each dimension has 5 levels: not at all, mild, moderate, severe, extreme. Participant marks most appropriate statement in each dimension, resulting in 1-digit number and digits from 5 dimensions can be combined in 5-digit number describing participant's health state. VAS component records a participant's overall self-rated health on a range of 0-100 with higher score indicates better self-reported health status. Outcome measure was evaluated based on data from in-trial observation period (defined as date of randomisation to one of the dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant \[who were lost to follow-up\], date of death).
Change in HbA1c - Percentage Week 0, week 104 Change in HbA1c (percentage) from randomisation (week 0) to week 104 is presented. The outcome measure was evaulated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Change in HbA1c - mmol/Mol Week 0, week 104 Change in HbA1c (mmol/mol) from randomisation (week 0) to week 104 is presented. The outcome measure was evaulated based on data from in-trial observation period. In-trial observation period defined as the period from date of randomisation to one of the following dates, whichever comes first: date of follow-up visit, date when participant withdrew consent, date of last contact with participant for participants who were lost to follow-up (participant did not complete the trial and did not withdraw consent), date of death.
Trial Locations
- Locations (830)
Mercy Hospital and Medical Center
🇺🇸Chicago, Illinois, United States
Preferred Primary Care Physicians Inc.
🇺🇸Pittsburgh, Pennsylvania, United States
Angel City Research, Inc.
🇺🇸Los Angeles, California, United States
VAGLAHS Clinical Research Center (CRC)
🇺🇸Los Angeles, California, United States
Parkside Family Medicine
🇺🇸Philadelphia, Pennsylvania, United States
University Of Maryland School of Medicine
🇺🇸Baltimore, Maryland, United States
Hospital of the Univ PA
🇺🇸Philadelphia, Pennsylvania, United States
Ascension Saint Agnes Heart Ca
🇺🇸Baltimore, Maryland, United States
UT Southwestern Med Cntr
🇺🇸Dallas, Texas, United States
Tristar Clin Investigations, PC
🇺🇸Philadelphia, Pennsylvania, United States
Thyroid, Endocrinology, and Diabetes, PA
🇺🇸Dallas, Texas, United States
Texas Health Physicians Group_Dallas
🇺🇸Dallas, Texas, United States
Brigham & Women's Hospital
🇺🇸Boston, Massachusetts, United States
Northwest Houston Cardiology, P.A.
🇺🇸Houston, Texas, United States
PlanIt Research, PLLC
🇺🇸Houston, Texas, United States
Reyes Clinical Research, Inc
🇺🇸Miami, Florida, United States
International Research Associates, LLC_Miami
🇺🇸Miami, Florida, United States
TriWest Research Associates
🇺🇸San Diego, California, United States
San Diego Family Care
🇺🇸San Diego, California, United States
Duke University_Durham
🇺🇸Durham, North Carolina, United States
Durham VA Medical Center - Duke University
🇺🇸Durham, North Carolina, United States
MidState Endocrine Associates
🇺🇸Nashville, Tennessee, United States
Sun Research Institute
🇺🇸San Antonio, Texas, United States
InvestiClin Research
🇺🇸Nashville, Tennessee, United States
Quality Research Inc
🇺🇸San Antonio, Texas, United States
San Antonio Prem Int Med
🇺🇸San Antonio, Texas, United States
Physician PrimeCare Research Institute, PLLC dba
🇺🇸San Antonio, Texas, United States
Audie L. Murphy Va Hospital, Stvhcs
🇺🇸San Antonio, Texas, United States
VIP Trials
🇺🇸San Antonio, Texas, United States
Synexus Rsch /Cnt Phnx Med C
🇺🇸Phoenix, Arizona, United States
Central Alabama Research
🇺🇸Birmingham, Alabama, United States
Univ of Alabama Birmingham
🇺🇸Birmingham, Alabama, United States
Oregon Health & Science Uni
🇺🇸Portland, Oregon, United States
University of NE Med Ctr
🇺🇸Omaha, Nebraska, United States
Medical Centre Pulss 5
🇱🇻Riga, Latvia
Centre de Recherche Clinique Portes Du Sud
🇫🇷Venissieux, France
National Heart Institute Cal
🇺🇸Beverly Hills, California, United States
Velocity Nova Sp. z o.o.
🇵🇱Pulawy, Poland
FDRC
🇺🇸Costa Mesa, California, United States
Synexus Clinical Research US, Inc./Tatum
🇺🇸Glendale, Arizona, United States
Healthscan Clinical Trials,LLC.
🇺🇸Montgomery, Alabama, United States
Synexus Clinical Research
🇺🇸Glendale, Arizona, United States
Scripps Whittier Diabetes Inst
🇺🇸La Jolla, California, United States
Valley Clinical Trials
🇺🇸Covina, California, United States
Torrance Clin Res Inst, Inc.
🇺🇸Lomita, California, United States
First Valley Medical Group
🇺🇸Lancaster, California, United States
Valley Clinical Trials, Inc.
🇺🇸Northridge, California, United States
Desert Oasis Hlthcr Med Group
🇺🇸Palm Springs, California, United States
Western University of Health Sciences
🇺🇸Pomona, California, United States
Riverside University Health System Medical Center
🇺🇸Moreno Valley, California, United States
Quartz Hill Walk-in Medical Group, inc.
🇺🇸Quartz Hill, California, United States
Mills-Peninsula Medical Center
🇺🇸San Mateo, California, United States
NorCal Endocrinology and Internal Medicine
🇺🇸San Ramon, California, United States
Encompass Clinical Research_Spring Valley
🇺🇸Spring Valley, California, United States
Lundquist Inst-Biomed Innovtn
🇺🇸Torrance, California, United States
Synexus Clinical Research US, Inc._Horsham
🇺🇸Vista, California, United States
Optumcare Colorado Springs, LLC
🇺🇸Colorado Springs, Colorado, United States
New West Physicians,Inc.
🇺🇸Golden, Colorado, United States
Optumcare Colorado Springs, LLC_Monument
🇺🇸Monument, Colorado, United States
Bridgeport Hospital
🇺🇸Bridgeport, Connecticut, United States
Chase Medical Research LLC
🇺🇸Waterbury, Connecticut, United States
Excel Med Ctr Clinical Trials
🇺🇸Boca Raton, Florida, United States
Fleming Island Center for Clinical Research
🇺🇸Fleming Island, Florida, United States
Clearwater Cardiovascular Consultants
🇺🇸Clearwater, Florida, United States
Nature Coast Clin Rsrch_Crystal River
🇺🇸Crystal River, Florida, United States
Northeast Research Institute
🇺🇸Fleming Island, Florida, United States
Est Cst Inst for Rsrch,Jksnvil
🇺🇸Jacksonville, Florida, United States
Clinical Research of Hollywood_Hollywood
🇺🇸Hollywood, Florida, United States
Jacksonville Ctr For Clin Res
🇺🇸Jacksonville, Florida, United States
Baptist Heart Specialists_Jacksonville Beach
🇺🇸Jacksonville Beach, Florida, United States
Baptist Heart Specialists_Jacksonville
🇺🇸Jacksonville, Florida, United States
Intercoastal Medical Group
🇺🇸Sarasota, Florida, United States
Oviedo Medical Research, LLC
🇺🇸Oviedo, Florida, United States
East Coast Institute for Research LLC
🇺🇸Saint Augustine, Florida, United States
Cardio Partners Clin Res Inst
🇺🇸Wellington, Florida, United States
Endocrine Research Solutions
🇺🇸Roswell, Georgia, United States
Family Health Care Center
🇺🇸Statesboro, Georgia, United States
Ellipsis Group
🇺🇸Alpharetta, Georgia, United States
Herman Clinical Research LLC
🇺🇸Suwanee, Georgia, United States
Atlanta Heart Specialists, LLC
🇺🇸Tucker, Georgia, United States
Northwest Heart Clinical Research, LLC
🇺🇸Arlington Heights, Illinois, United States
Apex Medical Research Inc
🇺🇸Chicago, Illinois, United States
Macoupin Research Group
🇺🇸Gillespie, Illinois, United States
Central Illinois Diabetes and Clinical Research
🇺🇸Springfield, Illinois, United States
Evanston Premier Hlthcr Res
🇺🇸Skokie, Illinois, United States
Chicago Medical Research LLC
🇺🇸Hazel Crest, Illinois, United States
Lemah Creek Clinical Research
🇺🇸Oakbrook Terrace, Illinois, United States
NorthShore Univ Hlth Sys
🇺🇸Skokie, Illinois, United States
MediSphere Medical Research Center, LLC
🇺🇸Evansville, Indiana, United States
Community Clinical Research_Anderson
🇺🇸Anderson, Indiana, United States
American Health Network of Indiana, LLC_Avon_0
🇺🇸Avon, Indiana, United States
Franciscan Health Michigan City
🇺🇸Michigan City, Indiana, United States
American Health Network of IN LLC_Franklin
🇺🇸Franklin, Indiana, United States
American Health Network of Indiana, LLC_Greenfield
🇺🇸Greenfield, Indiana, United States
University of Iowa Prev Inter Ctr
🇺🇸Iowa City, Iowa, United States
American Health Network of IN LLC
🇺🇸Muncie, Indiana, United States
American Health Network of Indiana, LLC
🇺🇸New Albany, Indiana, United States
Velocity Clinical_Valparaiso
🇺🇸Valparaiso, Indiana, United States
The University Of Kansas Medical Center - Cray Dia
🇺🇸Kansas City, Kansas, United States
Midwest Heart & Vasc Spec
🇺🇸Overland Park, Kansas, United States
Cotton O'Neil Clin Research Ctr
🇺🇸Topeka, Kansas, United States
Cambridge Medical Trials
🇺🇸Alexandria, Louisiana, United States
Anne Arundel Medical Center
🇺🇸Annapolis, Maryland, United States
Louisiana Heart Center
🇺🇸Hammond, Louisiana, United States
Barnum Medical Research, Inc.
🇺🇸Natchitoches, Louisiana, United States
Louisiana Heart Center_Slidell
🇺🇸Slidell, Louisiana, United States
MedStar Good Samaritan Hosp
🇺🇸Baltimore, Maryland, United States
Johns Hopkins University
🇺🇸Columbia, Maryland, United States
Centennial Medical Group
🇺🇸Elkridge, Maryland, United States
Endo And Metab Cons
🇺🇸Rockville, Maryland, United States
Henry Ford Health System
🇺🇸Detroit, Michigan, United States
ClinSite LLC.
🇺🇸Canton, Michigan, United States
Aa Mrc Llc
🇺🇸Flint, Michigan, United States
Belzoni Clinical Research
🇺🇸Belzoni, Mississippi, United States
Trinity Health Michigan Heart
🇺🇸Ypsilanti, Michigan, United States
Amicis Centers of Clinical Research
🇺🇸Saint Louis, Missouri, United States
Palm Research Center Inc-Vegas
🇺🇸Las Vegas, Nevada, United States
VA NEB - Western IA Health Stm
🇺🇸Omaha, Nebraska, United States
Synexus Clinical Research US
🇺🇸Henderson, Nevada, United States
St Louis Heart & Vascular, P.C.
🇺🇸Saint Louis, Missouri, United States
Mercury Street Medical Group, PLLC_Butte
🇺🇸Butte, Montana, United States
Southern NH Diabetes and Endo_Nashua
🇺🇸Nashua, New Hampshire, United States
UniMed Center
🇺🇸East Brunswick, New Jersey, United States
Long Island Cardiovascular Consultants PC
🇺🇸Lake Success, New York, United States
Holy Name Medical Center
🇺🇸Teaneck, New Jersey, United States
Comprehensive Weight Ctrl Prog
🇺🇸New York, New York, United States
Saratoga Clinical Research
🇺🇸Saratoga Springs, New York, United States
NYU Grossman School of Med
🇺🇸New York, New York, United States
NYU School of Medicine
🇺🇸New York, New York, United States
Albany Medical College - Endo
🇺🇸Albany, New York, United States
OnSite Clinical Solutions, LLC
🇺🇸Charlotte, North Carolina, United States
Great Lakes Medical Research
🇺🇸Westfield, New York, United States
WakeMed Garner Hlthplx
🇺🇸Garner, North Carolina, United States
Cleveland Clinic_Cleveland
🇺🇸Cleveland, Ohio, United States
The Carl & Edyth Lindner Center
🇺🇸Cincinnati, Ohio, United States
PMG Research of Winston-Salem
🇺🇸Winston-Salem, North Carolina, United States
Providence Health Partners Ctr
🇺🇸Dayton, Ohio, United States
Accellacare
🇺🇸Wilmington, North Carolina, United States
New Venture Medical Research
🇺🇸Wadsworth, Ohio, United States
Burke Primary Care
🇺🇸Morganton, North Carolina, United States
Physician's East Endocrinology
🇺🇸Greenville, North Carolina, United States
Corvallis Clinic PC Clinical Research Department
🇺🇸Corvallis, Oregon, United States
Harleysville Medical Associates
🇺🇸Harleysville, Pennsylvania, United States
Doylestown Hospital Pharmacy
🇺🇸Doylestown, Pennsylvania, United States
Richard M Kastelic MD Assoc
🇺🇸Johnstown, Pennsylvania, United States
Geisinger Clinic
🇺🇸Danville, Pennsylvania, United States
Holston Medical Group
🇺🇸Kingsport, Tennessee, United States
Internal Medicine Associates of Anderson
🇺🇸Anderson, South Carolina, United States
Synexus Clin Res US-Anderson
🇺🇸Anderson, South Carolina, United States
Palmetto Clinical Research
🇺🇸Greenville, South Carolina, United States
Accellacare US Inc._SC
🇺🇸Mount Pleasant, South Carolina, United States
Holston Medical Group Pc
🇺🇸Bristol, Tennessee, United States
Clinical Neuroscience Solutions
🇺🇸Memphis, Tennessee, United States
Amarillo Med Spec LLP
🇺🇸Amarillo, Texas, United States
Trinity Clinical Research LLC
🇺🇸Tullahoma, Tennessee, United States
Arlington Family Res. Ctr Inc
🇺🇸Arlington, Texas, United States
UT Health University of Texas
🇺🇸Bellaire, Texas, United States
DCOL Ctr for Clin Res
🇺🇸Longview, Texas, United States
Research Institute Of Dallas
🇺🇸Plano, Texas, United States
Simcare Medical Research, LLC
🇺🇸Sugar Land, Texas, United States
Houston Center for Clinical Research LLC
🇺🇸Sugar Land, Texas, United States
Christus Heart and Vascular Institute
🇺🇸Tyler, Texas, United States
Hillcrest Family Health Center
🇺🇸Waco, Texas, United States
Wade Family Medicine
🇺🇸Bountiful, Utah, United States
Kalo Clinical Research
🇺🇸West Valley City, Utah, United States
Cardiology Consultants of Danville Inc.
🇺🇸Danville, Virginia, United States
Inova Cardiology-Fairfax
🇺🇸Fairfax, Virginia, United States
U. of Vermont Med Ctr Burlington
🇺🇸South Burlington, Vermont, United States
Inova Cardiology - Mt. Vernon
🇺🇸Alexandria, Virginia, United States
York Clinical Research LLC
🇺🇸Norfolk, Virginia, United States
Strelitz Diabetes Of Eastern V.
🇺🇸Norfolk, Virginia, United States
Virginia Research Center
🇺🇸Midlothian, Virginia, United States
VA Medical Center_Salem
🇺🇸Salem, Virginia, United States
Capital Clin Res Ctr,LLC
🇺🇸Olympia, Washington, United States
Selma Medical Associates
🇺🇸Winchester, Virginia, United States
Amherst Family Practice P.C.
🇺🇸Winchester, Virginia, United States
Bayview Physician Services
🇺🇸Virginia Beach, Virginia, United States
Clinical Inv Spec, Inc.Kenosha
🇺🇸Kenosha, Wisconsin, United States
Cardiology department CHU Mustapha Pacha. Algiers
🇩🇿Algiers, Algeria
Centre National De la Médecine du Sport
🇩🇿Algiers, Algeria
CHU Issad Hassani, Beni Messous, Cardiology department
🇩🇿Algiers, Algeria
CHU - Hussein dey Cardiology department Nafissa Hamoud
🇩🇿Algiers, Algeria
Cardiology department, Benaouda Benzerdjeb CHU Oran
🇩🇿Oran, Algeria
Fundacion Favaloro
🇦🇷Caba, Buenos Aires, Argentina, Argentina
Sanatorio Güemes
🇦🇷Caba, City Of Buenos Aires, Argentina
Instituto de Cardiología de Corrientes
🇦🇷Corrientes, Buenos Aires, Argentina
Centro de Investigación y Prevención Cardiovascular
🇦🇷Caba, Argentina
Centro Médico MEDEOS
🇦🇷Caba, Argentina
Glenny Corp. S.A
🇦🇷Caba, Argentina
Clínica Adventista Belgrano
🇦🇷Caba, Argentina
Medical Center of Diabetes and Nutrition
🇦🇷Caba, Argentina
Instituto Médico DAMIC
🇦🇷Córdoba, Argentina
Sanatorio Plaza
🇦🇷Rosario, Argentina
The Canberra Hospital_Garran
🇦🇺Garran, Australian Capital Territory, Australia
Gosford Hospital
🇦🇺Gosford, New South Wales, Australia
Lyell McEwin Hospital
🇦🇺Elizabeth Vale, South Australia, Australia
Liverpool Hospital
🇦🇺Liverpool, New South Wales, Australia
Hunter Diabetes Centre
🇦🇺Merewether, New South Wales, Australia
Advara HeartCare
🇦🇺Milton, Queensland, Australia
Core Research Centre
🇦🇺Milton, Queensland, Australia
Cholesterol Care Australia
🇦🇺Wollongabba, Queensland, Australia
Austin Health, Metabolic Disorders Centre
🇦🇺Heidelberg Heights, Victoria, Australia
Monash Cardiovascular Research Centre
🇦🇺Clayton, Victoria, Australia
LKH Salzburg Universitätsklinikum
🇦🇹Salzburg, Austria
Geelong Cardiology Research Unit
🇦🇺Geelong, Victoria, Australia
Universitätsklinik für Innere Medizin
🇦🇹Graz, Austria
Univ.-Klinik für Innere Medizin I
🇦🇹Innsbruck, Austria
HeartCare WA (Joondalup)
🇦🇺Joondalup, Western Australia, Australia
Ordination Dr. Hanusch
🇦🇹Wien, Austria
Klinik Landstraße
🇦🇹Wien, Austria
Universitätsklinikum AKH Wien
🇦🇹Wien, Austria
Klinik Hietzing
🇦🇹Wien, Austria
Algemeen Stedelijk Ziekenhuis - Aalst - Interventional Cardiology
🇧🇪Aalst, Belgium
Imeldaziekenhuis - Bonheiden - Department of Endocrinology
🇧🇪Bonheiden, Belgium
CUB Hôpital Erasme_Brussels_1
🇧🇪Bruxelles, Belgium
Ziekenhuis Oost-Limburg AV - Cardiology
🇧🇪Genk, Belgium
UZ Gent - Cardiology
🇧🇪Gent, Belgium
UZ Gent_Gent_4
🇧🇪Gent, Belgium
Jessa Ziekenhuis - Hasselt - Cardiology
🇧🇪Hasselt, Belgium
Cárdio Pulmonar da Bahia
🇧🇷Salvador, Bahia, Brazil
Eurolatino Medical Research Center
🇧🇷Uberlândia, Minas Gerais, Brazil
Hospital do Coração do Brasil
🇧🇷Brasilia, Distrito Federal, Brazil
Cline Research Center
🇧🇷Curitiba, Parana, Brazil
Núcleo de Pesquisa Clínica S/S
🇧🇷Curitiba, Parana, Brazil
Hospital São Vicente de Paulo
🇧🇷Passo Fundo, Rio Grande Do Sul, Brazil
Instituto de Pesquisa Clínica de Campinas
🇧🇷Campinas, Sao Paulo, Brazil
CIP Centro Integrado de Pesquisas do Hospital de Base
🇧🇷São José do Rio Preto, Sao Paulo, Brazil
CPQuali Pesquisa Clínica Ltda
🇧🇷São Paulo, Sao Paulo, Brazil
CPCLIN - Centro de Pesquisas Clínicas
🇧🇷São Paulo, Sao Paulo, Brazil
Instituto Dante Pazzanese de Cardiologia
🇧🇷São Paulo, Sao Paulo, Brazil
Departamento de Gastroenterologia - HCFMUSP
🇧🇷São Paulo, Sao Paulo, Brazil
Instituto do Coração - HCFMUSP
🇧🇷São Paulo, Sao Paulo, Brazil
Instituto Brasil de Pesquisa Clinica
🇧🇷Rio de Janeiro, Brazil
Medical Centre Diamedical-2013
🇧🇬Dimitrovgrad, Bulgaria
"MHAT - Pazardzhik" AD, Second Department of Internal Diseas
🇧🇬Pazardzhik, Bulgaria
"UMBAL-Dr. Georgi Stranski" EAD, First Clinic of cardiology
🇧🇬Pleven, Bulgaria
MHAT Lukovit, Department of Internal Diseases
🇧🇬Lukovit, Bulgaria
"UMHAT "Sveti Georgi" EAD
🇧🇬Plovdiv, Bulgaria
Medical centre Razgrad OOD
🇧🇬Razgrad, Bulgaria
"MHAT "NCH" EAD, Cardiology clinic, Noninvasive diag. dep.
🇧🇬Sofia, Bulgaria
"MHAT "NCH" EAD, Clinic of Cardiology, Depart. of Cardiology
🇧🇬Sofia, Bulgaria
"Acibadem City Clinic MHAT Tokuda" EAD,Cardiology department
🇧🇬Sofia, Bulgaria
"Acibadem City Clinic UMHAT" EOOD, Sofia, Cardiology clinic
🇧🇬Sofia, Bulgaria
"Diagnostic - Consulting Center Aleksandrovska" EOOD
🇧🇬Sofia, Bulgaria
"UMHAT "Aleksandrovska" EAD, Cardiology clinic
🇧🇬Sofia, Bulgaria
"UMHAT "Tsaritsa Yoanna-ISUL"" EAD, Clinic of Cardiology
🇧🇬Sofia, Bulgaria
"UMHATEM N.I. Pirogov" EAD
🇧🇬Sofia, Bulgaria
"UMHAT "Sveta Anna" Sofia" AD, Clinic of Cardiology
🇧🇬Sofia, Bulgaria
"Diagnostic - Consulting Center "Ekvita"" EOOD
🇧🇬Varna, Bulgaria
Synergy Wellness Clinic
🇨🇦Sherwood Park, Alberta, Canada
University of Calgary
🇨🇦Calgary, Alberta, Canada
C-endo Diab Endo Clin Calgery
🇨🇦Calgary, Alberta, Canada
St. Joseph's Health Care
🇨🇦London, Ontario, Canada
Manna Research Inc. (Burlington N)
🇨🇦Burlington, Ontario, Canada
Cambridge Cardiac Care Centre
🇨🇦Cambridge, Ontario, Canada
Dr. James Cha
🇨🇦Oshawa, Ontario, Canada
Manna Research Ottawa
🇨🇦Nepean, Ontario, Canada
North York Diagn & Cardiac Ctr
🇨🇦North York, Ontario, Canada
Manna Research Inc._Toronto
🇨🇦Toronto, Ontario, Canada
Medical Associates of Port Perry
🇨🇦Port Perry, Ontario, Canada
The Port Arthur Clinic Research Program
🇨🇦Thunder Bay, Ontario, Canada
Manna Research Stoney Creek
🇨🇦Stoney Creek, Ontario, Canada
Kawartha Cardiology Clinical Trials
🇨🇦Peterborough, Ontario, Canada
HHI Research Inc.
🇨🇦Scarborough, Ontario, Canada
Manna Research Mirabel
🇨🇦Mirabel, Quebec, Canada
ViaCar Recherche Clinique Inc
🇨🇦Brossard, Quebec, Canada
Manna Research Quebec
🇨🇦Levis, Quebec, Canada
Clinique Sante Cardio MC
🇨🇦Montreal, Quebec, Canada
IRCM
🇨🇦Montreal, Quebec, Canada
Applied Med Inf Res
🇨🇦Montreal, Quebec, Canada
Centricity Res Pointe-Claire
🇨🇦Pointe-Claire, Quebec, Canada
Unidad de Estudios Clínicos de la Fundación Cardiovascular de Colombia
🇨🇴Bucaramanga-piedecuesta, Valle Del Menzuli - Santander, Santander, Colombia
Institut universitaire de cardiologie
🇨🇦Quebec, Canada
Rodrigo Botero S.A.S
🇨🇴Medellin, Antioquia, Colombia
IPS Centro Cientifico Asistencial Jose Luis Accini SAS
🇨🇴Barranquilla, Atlántico, Colombia
Centre de santé et de services
🇨🇦Terrebonne, Quebec, Canada
Clin des Mal Lipid de Quebec
🇨🇦Québec, Quebec, Canada
Ctr Méd. et pro d l'Ost d port
🇨🇦St-Marc-des-Carrières, Quebec, Canada
Fundacion del Caribe para la Investigacion Biomedica-BIOS
🇨🇴Barranquilla, Colombia
Clinica de la Costa
🇨🇴Barranquilla, Colombia
Centre de recherché du CHUS
🇨🇦Sherbrooke, Quebec, Canada
Centro de Investigacion Clinica Avanzada y Multidisciplinari
🇨🇴Medellin, Colombia
CardiovidCentro Cardiovascular Colombiano ClinicaSantaMaria
🇨🇴Medellin, Colombia
Poliklinika Solmed
🇭🇷Zagreb, Grad Zagreb, Croatia
Specijalna bolnica Krapinske Toplice - Kardiologija
🇭🇷Krapinske Toplice, Krapinsko Zagorska County, Croatia
Klinicki bolnicki centar Osijek
🇭🇷Osijek, Croatia
KBC Rijeka, Zavod za kardiomiopatije
🇭🇷Rijeka, Croatia
KBC "Sestre milosrdnice", Kardiologija
🇭🇷Zagreb, Croatia
KBC Zagreb, Klinika za bolesti srca i krvnih zila
🇭🇷Zagreb, Croatia
Klinicka bolnica Sveti Duh
🇭🇷Zagreb, Croatia
Fakultni poliklinika
🇨🇿Praha 2, Czech Republic, Czechia
Edumed Broumov
🇨🇿Broumov, Czechia
Ordinace pro choroby srdce
🇨🇿Chomutov, Czechia
Fakultni nemocnice Hradec Kralove_Hradec Kralove_0
🇨🇿Hradec Kralove, Czechia
Nemocnice Jihlava Kardiologie
🇨🇿Jihlava, Czechia
Kardiologické centrum
🇨🇿Liberec, Czechia
Policska nemocnice
🇨🇿Policka, Czechia
Endocare
🇨🇿Praha 4, Czechia
ResTrial
🇨🇿Praha 8, Czechia
Nemocnice Slany Kardiologie
🇨🇿Slany, Czechia
Svitavska nemocnice Kardiologie
🇨🇿Svitavy, Czechia
Vseobecna kardiologicka ambulance
🇨🇿Tabor, Czechia
Herlev og Gentofte Hospital
🇩🇰Hellerup, Region Hovedstaden, Denmark
Aalborg Universitetshospital Kardiologisk Afdeling
🇩🇰Aalborg, Denmark
Aarhus Universitetshospital, Skejby Hjertesygdomme
🇩🇰Aarhus N, Denmark
Regionshospitalet Gødstrup, Hjertesygdomme
🇩🇰Herning, Denmark
Hvidovre Hospital Hjertemedicinsk
🇩🇰Hvidovre, Denmark
Kardiologisk Odense & Svendborg
🇩🇰Svendborg, Denmark
StudyCor
🇫🇮Jyväskylä, Finland
Health Step Finland Oy
🇫🇮Kuopio, Finland
Päijät-Häme Central Hospital
🇫🇮Lahti, Finland
OYS Sisätautien tutkimusyksikkö
🇫🇮Oulu, Finland
Seinäjoen keskussairaala
🇫🇮Seinäjoki, Finland
TAYS Sydänsairaala
🇫🇮Tampere, Finland
TYKS Sydänkeskus
🇫🇮Turku, Finland
CHRU Besançon
🇫🇷Besançon, France
Hôpital Jean Verdier
🇫🇷Bondy, France
Centre Hospitalier Sud Francilien
🇫🇷Corbeil Essonnes, France
Les Hopitaux de Chartres-Hopital Louis Pasteur
🇫🇷Le Coudray, France
Centre Hospitalier de Narbonne
🇫🇷Narbonne, France
CHU de Nice
🇫🇷Nice, France
Centre Hospitalier Universitaire de Dijon-Hopital Le Bocage
🇫🇷DIJON cedex, France
Centre Hospitalier Universitaire Grenoble Alpes-Site Nord Michallon-1
🇫🇷La Tronche, France
Ap-Hp-Hopital Bichat-Claude Bernard-2
🇫🇷Paris Cedex 18, France
Chu Du Bocage
🇫🇷DIJON cedex, France
Aphp-Hopital La Pitie Salpetriere-2
🇫🇷Paris, France
Ap-Hp-Hopital Europeen Georges Pompidou
🇫🇷Paris, France
Hôpital Européen Georges Pompidou
🇫🇷Paris, France
Centre Hospitalier Universitaire de Bordeaux-Hopital Haut Leveque-2
🇫🇷Pessac, France
Centre Hospitalier Universitaire de Nantes-Hopital Nord Laennec-1
🇫🇷Saint Herblain, France
Klinische Forschung Berlin (kfgn)
🇩🇪Berlin, Germany
Universitaetsklinikum Aachen AöR
🇩🇪Aachen, Germany
Kardiologische Praxis
🇩🇪Bad Homburg, Germany
Les Hopitaux Universitaires de Strasbourg-Hopital Civil-2
🇫🇷Strasbourg, France
Emovis GmbH
🇩🇪Berlin, Germany
Synexus Berlin
🇩🇪Berlin, Germany
Synexus Bochum
🇩🇪Bochum, Germany
Klinische Forschung Dresden
🇩🇪Dresden, Germany
Hausaerztlich-Kardiologisches MVZ Am Felsenkeller GmbH
🇩🇪Dresden, Germany
Zentrum fuer klinische Studien Suedbrandenburg GmbH
🇩🇪Elsterwerda, Germany
InnoDiab Forschung GmbH
🇩🇪Essen, Germany
Synexus Frankfurt
🇩🇪Frankfurt, Germany
MVZ CCB Frankfurt Und Main-Taunus GbR
🇩🇪Frankfurt, Germany
Denger, Friedrichsthal
🇩🇪Friedrichsthal, Germany
Klinische Forschung Hamburg
🇩🇪Hamburg, Germany
Wendisch/Dahl Hamburg
🇩🇪Hamburg, Germany
Klinische Forschung Hannover
🇩🇪Hannover, Germany
Chevts
🇩🇪Karlsruhe, Germany
Appel
🇩🇪Kassel, Germany
Universitätsklinikum Leipzig, Endokrinologie und Nephrologie
🇩🇪Leipzig, Germany
AmBeNet GmbH
🇩🇪Leipzig, Germany
Die Praxis am Ludwigsplatz
🇩🇪Ludwigshafen, Germany
Universitätsklinikum Schleswig-Holstein
🇩🇪Lübeck, Germany
RED-Institut für medizinische Forschung und Fortbildung GmbH
🇩🇪Oldenburg in Holstein, Germany
Dr. Axthelm Christoph, Pirna
🇩🇪Pirna, Germany
Zentrum für klinische Studien Alexander Segner
🇩🇪Saint Ingbert-Oberwürzbach, Germany
Steindorf, Schkeuditz
🇩🇪Schkeuditz, Germany
Onassis Cardiac Surgery Center
🇬🇷Athens, Greece
Klinische Forschung Schwerin
🇩🇪Schwerin, Germany
Jacob, Villingen-Schwenningen
🇩🇪Villingen-Schwenningen, Germany
Forschungszentrum Ruhr KliFoCenter GmbH, Dr. med. Kahrmann
🇩🇪Witten, Germany
University Hospital of Athens ATTIKON
🇬🇷Haidari-Athens, Attica, Greece
Zentrum für klinische Studien Allgäu Oberschwaben
🇩🇪Wangen, Germany
Al-Zoebi
🇩🇪Wermsdorf, Germany
"Laiko" General Hospital of Athens
🇬🇷Athens, Greece
Hippokration Hospital
🇬🇷Athens, Greece
Konstantopouleio G.H. of Athens, "Agia Olga"
🇬🇷Athens, Greece
Alexandra General Hospital, Therapeutic Clinic
🇬🇷Athens, Greece
"Hygeia" General Hospital of Athens
🇬🇷Athens, Greece
Iatriko Athinon (Athens Medical Canter)
🇬🇷Athens, Greece
General Hospital of Chios "Skilitsio"
🇬🇷Chios, Greece
University General Hospital of Ioannina,Internal Medicine
🇬🇷Ioannina, Greece
General Hospital of Lamia
🇬🇷Lamia, Greece
Univ Gen Hospital Larisa, Cardiology Medicine Clinic
🇬🇷Larissa, Greece
AHEPA General University Hospital
🇬🇷Thessaloniki, Greece
"Thermi" Private Hosital
🇬🇷Thessaloniki, Greece
Lausmed Kft.
🇭🇺Baja, Bács-Kiskun Vármegye, Hungary
Szegedi Tudomanyegyetem St Györgyi Albert Klinikai Központ
🇭🇺Szeged, Csongrád-Csanád, Hungary
Léda Platán Magánklinika
🇭🇺Zalaegerszeg, Zala Megye, Hungary
Debreceni Egyetem Klinikai Központ Belgyógyászati Klinika
🇭🇺Debrecen, Hungary
Bugát Pál Kórház
🇭🇺Gyöngyös, Hungary
Markusovszky Egyetemi Oktatókórház
🇭🇺Szombathely, Hungary
Ramesh Hospitals
🇮🇳Vijayawada, Andhra Pradesh, India
Batra Hospital and Medical Research Center
🇮🇳New Delhi, Delhi, India
Apex Heart Institute
🇮🇳Ahmedabad, Gujarat, India
CIMS- Care Institute of Medical Sciences
🇮🇳Ahmedabad, Gujarat, India
Shri B. D. Mehta Mahavir Heart Institute
🇮🇳Surat, Gujarat, India
Unicare heart institute and research centre
🇮🇳Surat, Gujarat, India
Nirmal Hospital Pvt. Ltd.
🇮🇳Surat, Gujarat, India
Kamalnayan Bajaj Hospital
🇮🇳Aurangabad, Maharashtra, India
Tallaght Hospital - Cardiology
🇮🇪Dublin, Ireland
Medanta - The Medicity Multi-Speciality Hospital, Gurugram
🇮🇳Gurgaon, Haryana, India
St John's Medical College Hospital
🇮🇳Bengaluru, Karnataka, India
Sri Jayadeva Institute of Cardiovascular Sciences & Research
🇮🇳Bangalore, Karnataka, India
Vijan Hospital & Research Centre
🇮🇳Nashik, Maharashtra, India
Arneja Heart & Multispeciality Hospital
🇮🇳Nagpur, Maharashtra, India
Shri Krishna Hrudayalaya & Critical Care Centre
🇮🇳Nagpur, Maharashtra, India
Seth GS medical college and KEM Hospital
🇮🇳Mumbai, Maharashtra, India
Mallow Primary Healthcare Centre
🇮🇪Mallow, Ireland
Holy Family Hospital and Medical Research Centre
🇮🇳Mumbai, Maharashtra, India
Dayanand Medical College & Hospital
🇮🇳Ludhiana, Punjab, India
The Madras Medical Mission
🇮🇳Chennai, Tamil Nadu, India
SP Medical College
🇮🇳Bikaner, Rajasthan, India
VMMC & Safdarjung Hospital
🇮🇳New Dehli, New Delhi, India
Maulana Azad Medical College
🇮🇳Delhi, New Delhi, India
All India Institute of Medical Sciences
🇮🇳New Dehli, New Delhi, India
Christian Medical College Hospital, Vellore
🇮🇳Vellore, Tamil Nadu, India
Guru Nanak CARE Hospitals
🇮🇳Hyderabad, Telangana, India
B M Birla Heart Research Centre
🇮🇳Kolkata, West Bengal, India
Gandhi Memorial Hospital- King George's Medical University
🇮🇳Lucknow, Uttar Pradesh, India
Osmania General Hospital
🇮🇳Hyderabad, Telengana, India
Narayana Hrudayalya Institute of Cardiac Sciences
🇮🇳Bangalore, India
St John's Medical College and Hospital
🇮🇳Bangalore, India
Dr. BL Kapur Memorial Hospital
🇮🇳New Delhi, India
Sir Ganga Ram Hospital
🇮🇳New Delhi, India
Connolly Hospital
🇮🇪Dublin, Leinster, Ireland
The Heartbeat Trust
🇮🇪Dublin, Ireland
St Vincent's Private Hospital
🇮🇪Dublin, Ireland
Outpatient Diabetes Clinic Soroka MC
🇮🇱Beer Sheva, Israel
Diabetes and obesity center of excellence, Rambam MC
🇮🇱Haifa, Israel
Hadassah Ein Kerem MC - Cardio
🇮🇱Jerusalem, Israel
Diabetes Unit Hadassah Ein Karem MC
🇮🇱Jerusalem, Israel
Clinical Research Unit Meir Medical Center
🇮🇱Kfar Saba, Israel
Institute of Diabetes, Western Galilee MC Nahariya
🇮🇱Nahariya, Israel
Rabin Medical Center - Hasharon Hospital, Dept. D
🇮🇱Petah-Tikva, Israel
Kaplan MC
🇮🇱Rehovot, Israel
Endrocrinolgy Clinic - Sheba Medical Center
🇮🇱Tel Hashomer, Israel
Sheba Medica Center - Clinical Research Unit
🇮🇱Tel Hashomer, Israel
Institute of Endocrinology, metabolism and hypertension
🇮🇱Tel-Aviv, Israel
Ospedale Santa Maria Goretti - UOD Diabetologia
🇮🇹Latina, LT, Italy
Centro di Alta Spec. Diet., Educ. Alim. e Prev. Cardio Metab
🇮🇹San Donato Milanese (MI), Italy
Cardio Vascular Research Center Sourasky MC
🇮🇱Tel Aviv, Israel
Pol. Uni. Campus Biomedico UOC Endocrinologia e Diabetologia
🇮🇹Roma, RM, Italy
AO Papa Giovanni XXIII USS Dietologia Clinica
🇮🇹Bergamo, Italy
A. O. Universitaria S.ORSOLA-MALPIGHI - U. O. Endocrinologia
🇮🇹Bologna, Italy
ARNAS Ospedale Garibaldi
🇮🇹Catania, Italy
Università degli studi G. D'Annunzio Chieti Pescara - CAST
🇮🇹Chieti Scalo, Italy
Ospedale di San Fermo della Battaglia
🇮🇹Como, Italy
Azienda Osp-Univ Ferrara-Dip Scienze Mediche-Endocrinologia
🇮🇹Cona - Ferrara, Italy
AOU Careggi Dipartimento Medico Geriatrico SOD Diabetologia
🇮🇹Firenze, Italy
U.O.D. Dietetica e Nutrizione Clinica
🇮🇹Genova, Italy
Azienda Ospedaliera di Padova Clin.Med.3
🇮🇹Padova, Italy
Unità Funzionale di nutrizione clinica cod 58.01.3
🇮🇹Palermo, Italy
Azienda Ospedaliera Universitaria Federico II di Napoli
🇮🇹Napoli, Italy
IRCCS Fondazione "S. Maugeri" U.O. Medicina Interna ed Endo
🇮🇹Pavia, Italy
Azienda Ospedaliero Universitaria Pisana Ospedale Cisanello
🇮🇹Pisa, Italy
UOC di Medicina Interna - Centro Medico dell'Obesità
🇮🇹Roma, Italy
Policlinico Universitario AGemelli DH Patologie dell'Obesità
🇮🇹Rome, Italy
Ist.Clinico Humanitas Endocrinologia e Malattie del ricambio
🇮🇹Rozzano (MI), Italy
Osp. Santissima Annunziata ASL CN1 Endocrinol. Diabetol.
🇮🇹Savigliano (CN), Italy
A.O.U. Città della Salute e della Scienza di Torino
🇮🇹Torino, Italy
Seiwa Clinic
🇯🇵Adachi-ku, Tokyo, Japan
IRCCS Multimedica
🇮🇹Sesto San Giovanni (MI), Italy
A.O.U. Senese Policlinico "Le Scotte" , U.O.C. Diabetologia
🇮🇹Siena, Italy
Toyooka Chuo Hospital
🇯🇵Asahikawa, Hokkaido, Japan
The Univ. of Tokyo Hp., Dept. of Cardiovascular Medicine
🇯🇵Bunkyo-ku, Tokyo, Japan
New Tokyo Heart Clinic_Matsudo-shi, Chiba,
🇯🇵Chiba, Japan
Fukuokaken Saiseikai Futsukaichi Hospital_Cardiovascular Medicine
🇯🇵Chikushino-shi, Fukuoka, Japan
Ehime Prefectural Central Hospital
🇯🇵Ehime, Japan
Chiba Tokushukai Hospital
🇯🇵Funabashi-shi, Chiba, Japan
Gifu Heart Center
🇯🇵Gifu-city, Gifu, Japan
Hirakata Kohsai Hospital
🇯🇵Hirakata-shi, Osaka, Japan
Medical Corporation JR Hiroshima Hospital
🇯🇵Hiroshima-shi, Hiroshima, Japan
Hiroshi Yamaguchi Clinic
🇯🇵Kagoshima-shi, Kagoshima, Japan
Kasugai Municipal Hospital
🇯🇵Kasugai-shi, Aichi, Japan
Sugiura Clinic
🇯🇵Kawaguchi-shi, Saitama, Japan
H.E.C Science Clinic
🇯🇵Kanagawa, Japan
Steel Memorial Yawata Hospital
🇯🇵Kitakyushu-shi, Fukuoka, Japan
Stradini Cardiology
🇱🇻Riga, Latvia
Chikamori Hospital
🇯🇵Kochi-shi, Kochi, Japan
Saiseikai Kumamoto Hospital
🇯🇵Kumamoto-shi, Kumamoto, Japan
Uji Tokushukai Medical Center
🇯🇵Kyoto, Japan
Koseikai Takeda Hospital
🇯🇵Kyoto-shi, Kyoto, Japan
Ijinkai Takeda General Hospital, Cardiovascular Medicine
🇯🇵Kyoto-shi,Kyoto, Japan
Ijinkai Takeda General Hospital, Neurosurgery
🇯🇵Kyoto-shi,Kyoto, Japan
Medical Corporation Matsuyama-heartcenter Yotsuba Circulatio
🇯🇵Matsuyama-shi, Ehime, Japan
Shiga General Hospital
🇯🇵Moriyama-shi, Shiga, Japan
Naha City Hospital
🇯🇵Naha-shi, Okinawa, Japan
Takagi hospital, Internal Medicine
🇯🇵Okawa-shi, Fukuoka, Japan
Medical corporation Sanseikai Miyanomori Memorial Hospital
🇯🇵Sapporo-shi, Hokkaido, Japan
National Center for Global Health and Medicine
🇯🇵Shinjuku-ku, Tokyo, Japan
Kan-etsu chu-oh Hospital
🇯🇵Takasaki-shi, Gunma, Japan
Shinden Higashi Clinic_Miyagi
🇯🇵Miyagi, Japan
Takatsuki Red Cross Hospital
🇯🇵Osaka, Japan
Saga University Hospital, Department of Cardiology
🇯🇵Saga-shi, Saga, Japan
Hanaoka Seishu Memorial Hospital
🇯🇵Sapporo-shi, Hokkaido, Japan
Sendai Kousei Hospital_Sendai-shi, Miyagi
🇯🇵Sendai-shi, Miyagi, Japan
Saino Clinic
🇯🇵Tokorozawa-shi,Saitama, Japan
Tokyo Shinagawa Hospital Social Medical Corporation Association Tokyokyojuno-kai
🇯🇵Tokyo, Japan
Minamino Cardiovascular Hospital
🇯🇵Tokyo, Japan
Nagata Hospital
🇯🇵Yanagawa-shi, Fukuoka, Japan
Nagoya Ekisaikai Hospital
🇯🇵Nagoya-shi, Aichi, Japan
Shinsapporo Seiryou Hospital, Intenal Medicine
🇯🇵Sapporo-shi, Hokkaido, Japan
Sakurabashi Watanabe Advanced Healthcare Hospital
🇯🇵Osaka-city, Osaka, Japan
Kagawa Prefectural Central Hospital
🇯🇵Takamatsu-shi, Kagawa, Japan
Okayama Medical Center
🇯🇵Okayama-shi, Okayama, Japan
Tokyo-Eki Center-building Clinic
🇯🇵Tokyo, Japan
Japan Community Health care Organization Ritsurin Hospital
🇯🇵Takamatsu-shi, Kagawa, Japan
Tokorozawa Heart Center
🇯🇵Tokorozawa-shi, Saitama, Japan
Yokosuka General Hospital Uwamachi, Cardiology
🇯🇵Yokosuka-shi, Kanagawa, Japan
Ari Med
🇱🇻Daugavpils, Latvia
Kagawa Prefectural Central Hospital, Cardiovascular Medicine
🇯🇵Takamatsu-shi, Kagawa, Japan
Fukuwa Clinic
🇯🇵Tokyo, Japan
Meissana Ltd
🇱🇻Liepaja, Latvia
National Hospital Organization Saitama National Hospital
🇯🇵Wako-city, Saitama, Japan
Teterovska practice
🇱🇻Ogre, Latvia
Adoria
🇱🇻Riga, Latvia
Health Centre-4
🇱🇻Riga, Latvia
Ziemelkurzeme Regional Hospital
🇱🇻Ventspils, Latvia
Hospital Tengku Ampuan Afzan
🇲🇾Kuantan, Malaysia
Hospital Universiti Sains Malaysia
🇲🇾Kota Bharu, Kelantan, Malaysia
Hospital Seri Manjung
🇲🇾Seri Manjung, Perak, Malaysia
Sarawak Heart Centre
🇲🇾Kota Samarahan, Malaysia
University Technology MARA (UiTM) - Puncak Alam
🇲🇾Sungai Buloh, Selangor, Malaysia
Klinik Kesihatan Masjid Tanah
🇲🇾Alor Gajah, Malaysia
Sykehuset Innlandet Lillehammer
🇳🇴Lillehammer, Norway
Hospital Sultanah Bahiyah
🇲🇾Alor Setar, Malaysia
National Heart Institute
🇲🇾Kuala Lumpur, Malaysia
University Malaya Medical Centre
🇲🇾Kuala Lumpur, Malaysia
Hospital Putrajaya
🇲🇾Putrajaya, Malaysia
Hospital Queen Elizabeth II
🇲🇾Sabah, Malaysia
CIMAB SA de CV
🇲🇽Torreon, Coahuila, Mexico
Centro de Investigacion Clinica Endocrinologica de Jalisco
🇲🇽Guadalajara, Jalisco, Mexico
Instituto Nacional de Cardiología Ignacio Chavez
🇲🇽Ciudad de Mexico, México, D.F., Mexico
Akershus Universitetssykehus
🇳🇴Nordbyhagen, Norway
Centro de atención e investigación cardiovascular del Potosí
🇲🇽San Luis Potosí, San Luis Potosi, Mexico
Hospital Universitario Dr. José Eleuterio González_Monterrey
🇲🇽Monterrey, Nuevo León, Mexico
Centro para el Desarrollo de la Medicina y la Asistencia
🇲🇽Culiacán, Sinaloa, Mexico
Centro de Investigación Cardiometabólica de Aguascalientes
🇲🇽Aguascalientes, Mexico
Lahoja Asociación para la Investigación y Farmacovigilancia
🇲🇽Durango, Mexico
Gelre Ziekenhuizen Apeldoorn
🇳🇱Apeldoorn, Netherlands
Medisch Centrum Leeuwarden
🇳🇱Leeuwarden, Netherlands
Alrijne Leiderdorp
🇳🇱Leiderdorp, Netherlands
Amphia Ziekenhuis
🇳🇱Breda, Netherlands
Deventer Ziekenhuis
🇳🇱Deventer, Netherlands
UMC Groningen
🇳🇱Groningen, Netherlands
Bravis Ziekenhuis
🇳🇱Roosendaal, Netherlands
Franciscus Gasthuis en Vlietland
🇳🇱Rotterdam, Netherlands
D & A Research B.V.
🇳🇱Sneek, Netherlands
Ziekenhuis Rivierenland Tiel
🇳🇱Tiel, Netherlands
Haukeland Universitetssykehus
🇳🇴Bergen, Norway
Falck Norge AS
🇳🇴Hamar, Norway
Rikshospitalet - Kardiologisk forskning
🇳🇴Oslo, Norway
Oslo universitetssykehus HF Ullevål
🇳🇴Oslo, Norway
Oslo universitetssykehus Aker
🇳🇴Oslo, Norway
Senter for sykelig overvekt i Helse Sør-Øst
🇳🇴Tønsberg, Norway
Ålesund Sjukehus - Hjertemedisinsk poliklinikk
🇳🇴Ålesund, Norway
Clinmedica Research sp. z o.o.
🇵🇱Skierniewice, Lodzkie, Poland
NZOZ "CenterMed Lublin" Sp. z o.o.
🇵🇱Lublin, Lubelskie, Poland
ETG Siedlce
🇵🇱Siedlce, Masovian, Poland
ETG Warszawa
🇵🇱Warsaw, Masovian, Poland
Gabinet Leczenia Otylosci i Chorob Dietozaleznych
🇵🇱Bialystok, Podlaskie Voivodeship, Poland
Kresmed Sp. z o. o.
🇵🇱Bialystok, Podlaskie, Poland
Centrum Medyczne Pratia Gdynia
🇵🇱Gdynia, Pomorskie, Poland
PRATIA Centrum Medyczne
🇵🇱Gdynia, Pomorskie, Poland
Centrum Zdrowia Metabolicznego
🇵🇱Poznan, Wielkopolskie Voivodeship, Poland
Poradnia Kardiologiczna Jaroslaw Jurowiecki
🇵🇱Gdansk, Poland
Centrum Badan Klinicznych PI-House
🇵🇱Gdansk, Poland
Grazyna Pulka Specjalistyczny Osrodek "All-Med"
🇵🇱Krakow, Poland
UniCardia & UniMedica & UniEstetica
🇵🇱Krakow, Poland
Centrum Terapii Wspolczesnej
🇵🇱Lodz, Poland
Klimed Lomza
🇵🇱Lomza, Poland
ETG Lowicz
🇵🇱Lowicz, Poland
Centrum Medyczne HCP Sp. z o.o.
🇵🇱Poznan, Poland
Gabinety Lekarskie LabMed
🇵🇱Szczecin, Poland
Przychodnia Lekarzy Specjalistow Serce
🇵🇱Warszawa, Poland
Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych I Administracji
🇵🇱Warszawa, Poland
Velocity Zamość
🇵🇱Zamosc, Poland
Hospital Garcia de Orta
🇵🇹Almada, Portugal
Centro Hospitalar e Universitário de Coimbra
🇵🇹Coimbra, Portugal
Hospital da Luz
🇵🇹Lisboa, Portugal
Centro Hospitalar Lisboa Norte
🇵🇹Lisboa, Portugal
Unidade Local de Saúde de Matosinhos
🇵🇹Matosinhos, Portugal
Centro Hospitalar de São João
🇵🇹Porto, Portugal
San Miguel Medical
🇵🇷Trujillo Alto, Puerto Rico
SC Grand Med SRL
🇷🇴Oradea, Bihor, Romania
S.C. Endodigest S.R.L.
🇷🇴Oradea, Bihor, Romania
SC Ames Research Center SRL
🇷🇴Clarasi, Calaras, Romania
S.C. Centrul Medical Unirea S.R.L.
🇷🇴Cluj Napoca, Cluj, Romania
S.C. Top Diabet Srl
🇷🇴Craiova, Dolj, Romania
County Hospital Deva
🇷🇴Deva, Hunedoara, Romania
CMI Dr Pop Lavinia
🇷🇴Baia Mare, Maramures, Romania
Sc Mediab Srl
🇷🇴Targu Mures, Mures, Romania
3rd Clinic for Nutrition-Spitalulul Județean de Urgenta
🇷🇴Timisoara, Timis, Romania
SC Cardiomed SRL
🇷🇴Iasi, Romania
Minimed S.R.L.
🇷🇴Bacau, Romania
Centrul Medical de Diagnostic si Tratament Ambulatoriu Neomed
🇷🇴Brasov, Romania
Sc Nicodiab Srl
🇷🇴Bucharest, Romania
"Carol Davila" Military Emergency Hospital
🇷🇴Bucharest, Romania
Sana Monitoring SRL
🇷🇴Bucharest, Romania
SC Eco-Diagnosis SRL
🇷🇴Bucharest, Romania
Institutul National de Endocrinologie C.I. Parhon
🇷🇴Bucuresti, Romania
S.C. Medcon S.R.L
🇷🇴Buzau, Romania
S.C Milena Sante SRL
🇷🇴Galati, Romania
SC Diamed Obesity SRL
🇷🇴Galati, Romania
SC Consultmed SRL
🇷🇴Iasi, Romania
Centrul Medical Bella Praxis
🇷🇴Pascani, Romania
Bella Praxis S.R.L.
🇷🇴Pascani, Romania
S.C. Dianutrilife Medica S.R.L.
🇷🇴Ploiesti, Romania
County Emergency Hospital Satu Mare
🇷🇴Satu Mare, Romania
SC Gensan SRL, Policlinica ASTRA
🇷🇴Sibiu, Romania
Tumen State Medical University
🇷🇺Tumen, Russia, Russian Federation
Volosevich First City Clinical Hospital
🇷🇺Arkhangelsk, Russian Federation
Reg. State Budget Healthc. Inst. Regional Clinical Hospital
🇷🇺Barnaul, Russian Federation
City Hospital #5
🇷🇺Barnaul, Russian Federation
RBSHI "Altay Regional Cardiology Dispensary"
🇷🇺Barnaul, Russian Federation
Belgorod regional clinical hospital of the St. Ioasaph
🇷🇺Belgorod, Russian Federation
Urals State Medical University
🇷🇺Ekaterinburg, Russian Federation
Cardiological dispensary
🇷🇺Ivanovo, Russian Federation
KSFMU, Inrereginal Clinical Diagnostic center
🇷🇺Kazan, Russian Federation
Institute of Complex Problems of Cardio-Vascular Diseases
🇷🇺Kemerovo, Russian Federation
Medical Center CAPITAL-HEALTH
🇷🇺Moscow, Russian Federation
Moscow City Clinical Hospital #15
🇷🇺Moscow, Russian Federation
Friendship University of Russia
🇷🇺Moscow, Russian Federation
Moscow State University n.a. M.V. Lomonosov
🇷🇺Moscow, Russian Federation
National Medical Research Center of Cardiology
🇷🇺Moscow, Russian Federation
City Clinical Hospital №52
🇷🇺Moscow, Russian Federation
Federal Bureau for Medical and Social Expertise
🇷🇺Moscow, Russian Federation
PHI "Central Clinical Hospital RZD- Medicine"
🇷🇺Moscow, Russian Federation
Moscow City Clinical Hospital n.a. A.K. Eramishantseva
🇷🇺Moscow, Russian Federation
LLC RC Medical
🇷🇺Novosibirsk, Russian Federation
Limited Law Company "Healthy Family" Medicine Center"
🇷🇺Novosibirsk, Russian Federation
LLC Reafan
🇷🇺Novosibirsk, Russian Federation
Scientific Research Institute of neuroscience and Medicine
🇷🇺Novosibirsk, Russian Federation
Orenburg Regional Clinical Hospital
🇷🇺Orenburg, Russian Federation
Penza Regional Clinical Hospital named after N.N. Burdenko
🇷🇺Penza, Russian Federation
Rostov State Medical University_Rostov-on-Don
🇷🇺Rostov-on-Don, Russian Federation
SPb SBHI City Outpatient clinic #109
🇷🇺Saint Petersburg, Russian Federation
SPb SBHI City Hospital #38 n.a. N.A. Semashko
🇷🇺Saint-Petersburg, Pushkin, Russian Federation
City policlinic #28
🇷🇺Saint-Petersburg, Russian Federation
Joint Stock Company "Modern Medical Technologies"
🇷🇺Saint-Petersburg, Russian Federation
SPb SBHI City Outpatient clinic #37
🇷🇺Saint-Petersburg, Russian Federation
Limited Liability Company "Energiya Zdoroviya"
🇷🇺Saint-Petersburg, Russian Federation
SPb SBHI City polyclinic #117
🇷🇺Saint-Petersburg, Russian Federation
Astarta Clinic LLC
🇷🇺Saint-Petersburg, Russian Federation
FSPbSMU n.a. Academic I.P. Pavlov
🇷🇺Saint-Petersburg, Russian Federation
Consultative & Diagnostic Center with a Outpatient Hospital
🇷🇺Saint-Petersburg, Russian Federation
Saint-Petersburg "City Policlinic # 74"
🇷🇺Saint-Petersburg, Russian Federation
Regional Clinical cardiological dispensary n.a. Polyakov
🇷🇺Samara, Russian Federation
City Hospital #4, Sochi
🇷🇺Sochi, Russian Federation
SPb SBHI City Multifield Hospital #2
🇷🇺St. Petersburg, Russian Federation
SAHI of Komi Republic "Consultative Diagnostic Center"
🇷🇺Syktyvkar, Russian Federation
Tomsk National Research Medical Center of the RAS
🇷🇺Tomsk, Russian Federation
Tomsk Regional Clinical Hospital
🇷🇺Tomsk, Russian Federation
Siberian State Medical University_Tomsk
🇷🇺Tomsk, Russian Federation
Tumen State Medical University - RIMBB
🇷🇺Tumen, Russian Federation
Regional Clinical Hospital of Tver
🇷🇺Tver, Russian Federation
Ulianovsk Regional Clinical Hospital
🇷🇺Ulianovsk, Russian Federation
Voronezh Regional Clinical Consultive-diagnostic Centre
🇷🇺Voronezh, Russian Federation
Solovyov Clinical Emergency Hospital
🇷🇺Yaroslavl, Russian Federation
Clinical centre of Serbia, Clinic for cardiology
🇷🇸Belgrade, Serbia
Clinical Centre of Serbia, Emergency Centre, Department of Cardiology
🇷🇸Belgrade, Serbia
Emergency Internal Medicine Clinic
🇷🇸Belgrade, Serbia
Endocrinology, Diabetes and Metabolism Diseases Clinic
🇷🇸Belgrade, Serbia
Special Hospital "Sveti Sava"
🇷🇸Belgrade, Serbia
Cardiology Research_Bloemfontein
🇿🇦Bloemfontein, Free State, South Africa
Phoenix Pharma
🇿🇦Port Elizabeth, Eastern Cape, South Africa
IATROS International
🇿🇦Bloemfontein, Free State, South Africa
Josha Research
🇿🇦Bloemfontein, Free State, South Africa
Dr Iftikhar Osman Ebrahim
🇿🇦Centurion, Gauteng, South Africa
CRISMO
🇿🇦Germiston, Gauteng, South Africa
Wits Bara Clinical Trial Site
🇿🇦Johannesburg, Gauteng, South Africa
Jongaie Research
🇿🇦Pretoria, Gauteng, South Africa
Synexus Watermeyer Clinical Research Centre
🇿🇦Pretoria, Gauteng, South Africa
Clinical Trial Systems (CTC)
🇿🇦Pretoria, Gauteng, South Africa
Dr Moosa's Rooms
🇿🇦Lenasia, Gauteng, South Africa
Lenasia Clinical Trial Centre
🇿🇦Lenasia, Gauteng, South Africa
Roodepoort Medicross Clinical Research Centre
🇿🇦Roodepoort, Gauteng, South Africa
Dr S Dawood
🇿🇦Cape Town, Western Cape, South Africa
Dr Jugnundan's Rooms
🇿🇦Durban, KwaZulu-Natal, South Africa
Dr Corbett
🇿🇦Cape Town, Western Cape, South Africa
Tread Research (Pty)Ltd
🇿🇦Cape Town, Western Cape, South Africa
Paarl Research Centre
🇿🇦Paarl, Western Cape, South Africa
Clinical Projects Research
🇿🇦Worcester, Western Cape, South Africa
Synexus Helderberg Clinical Research Centre
🇿🇦Somerset West, Western Cape, South Africa
Cape Town Medical Research Centre
🇿🇦Kuilsriver, Western Cape, South Africa
Centro Periférico de Especialidades Bola Azul
🇪🇸Almeria, Spain
Hospital Gregorio Marañón
🇪🇸Madrid, Spain
Complejo Hospitalario Universitario A Coruña
🇪🇸La Coruña, Spain
Hospital Clínico Virgen de la Victoria
🇪🇸Málaga, Spain
Phramongkutklao Hospital-neuro
🇹🇭Bangkok, Thailand
Hospital Son Llatzer
🇪🇸Palma de Mallorca, Spain
Clínica Nuevas Tecnologías en Diabetes y Endocrinología
🇪🇸Sevilla, Spain
Hospital Virgen de la Macarena
🇪🇸Sevilla, Spain
Hospital Infanta Luisa
🇪🇸Sevilla, Spain
Hospital La Fe - Endocrinología y Nutrición
🇪🇸Valencia, Spain
Lundberglab for Diab Research
🇸🇪Göteborg, Sweden
Centralsjukhuset, Kristianstad
🇸🇪Kristianstad, Sweden
Clemenstorgets Hjärtmottagning
🇸🇪Lund, Sweden
Karolinska Universitetssjukhuset Solna,FOU Tema Hjärta Kärl
🇸🇪Stockholm, Sweden
Enheten för Kliniska Studier (EKS), Örebro
🇸🇪Örebro, Sweden
Hjärtenheten
🇸🇪Östersund, Sweden
HsinChu MacKay Memorial Hospital
🇨🇳Hsinchu City, Taiwan
E-DA Hosiptal
🇨🇳Kaohsiung City, Taiwan
MacKay Memorial Hospital-Tamsui Branch
🇨🇳New Taipei City, Taiwan
National Taiwan University Hospital
🇨🇳Taipei, Taiwan
Chang Gung Memorial Hospital Linkou
🇨🇳Taoyuan City, Taiwan
Erciyes University Cardiology
🇹🇷Kayseri, Turkey
Maharaj Nakorn Chiang Mai Hospital
🇹🇭Chiang Mai, Mueang Chiang Mai District, Thailand
Thammasat University Hospital
🇹🇭Klong Luang, Pathumthani, Pathumthani, Thailand
Siriraj Hospital_Bangkok_1
🇹🇭Bangkok, Thailand
King Chulalongkorn Memorial Hospital_Bangkok
🇹🇭Bangkok, Thailand
Phramongkutklao Hospital-cardio
🇹🇭Bangkok, Thailand
Ramathibodi Hospital-Cardiovascular metabolic Center
🇹🇭Bangkok, Thailand
Maharaj Nakorn Chiang Mai Hospital-cardio
🇹🇭Chiang Mai, Thailand
Srinakarind Hospital-Division of Cardiology
🇹🇭Khon kaen, Thailand
Baskent Universitesi Adana
🇹🇷Adana, Turkey
Cukurova University School of Medicine Balcali Hospital
🇹🇷Adana, Turkey
Gulhane Egitim Arastirma Hastanesi
🇹🇷Ankara, Turkey
Hacettepe Universitesi Tip Fakultesi Hastanesi
🇹🇷Ankara, Turkey
Akdeniz University Tip Fakultesi Hastanesi
🇹🇷Antalya, Turkey
Adnan Menderes Universitesi Uygulama ve Arastirma Hastanesi
🇹🇷Aydin, Turkey
Eskisehir Osmangazi University-Cardio
🇹🇷Eskisehir, Turkey
Istanbul Universitesi Istanbul Tip Fakultesi - Endokrinoloji
🇹🇷Istanbul, Turkey
Gaziantep Universitesi Tip Fakultesi Hastanesi
🇹🇷Gaziantep, Turkey
Fatih Sultan Mehmet Hastanesi
🇹🇷Istanbul, Turkey
Seyrantepe Hamidiye Etfal Egitim ve Arastirma Hastanesi
🇹🇷Istanbul, Turkey
Umraniye Egitim ve Arastirma Hastanesi
🇹🇷Istanbul, Turkey
T.C. Saglik Bakanligi Pendik Egitim ve Arastirma Hastanesi
🇹🇷Istanbul, Turkey
Ege University School of Medicine, Cardiology Department
🇹🇷Izmir, Turkey
Koc University Hospital
🇹🇷Istanbul, Turkey
Dokuz Eylul University School of Medicine, Cardiology
🇹🇷Izmir, Turkey
TC SB Ist.İl Sag.Müd.Prof.Dr.Cemil Tascioglu Sehir Hastanesi
🇹🇷Istanbul, Turkey
Mersin University Cardiology
🇹🇷Mersin, Turkey
Izmir Tepecik Training and Research Hospital
🇹🇷Izmir, Turkey
Cumhuriyet University School of Medicine-Cardiology
🇹🇷Sivas, Turkey
CMI City Clinical Hospital #3
🇺🇦Chernivtsi, Ukraine
CNPI "Kharkiv City Clinical Hospital #27"
🇺🇦Kharkiv, Ukraine
NI of Therapy na LT Malaya of NAMSU - Chr. Non-Communicable
🇺🇦Kharkiv, Ukraine
Oleksandrivska Clinical Hospital - cardio rehabilitation dep
🇺🇦Kyiv, Ukraine
Medical Center of LLC 'Harmoniya Krasy'
🇺🇦Kyiv, Ukraine
Medical Center 'Ok!Clinic+' of II of Clinical Studies LLC
🇺🇦Kyiv, Ukraine
Kyiv City Clinical Hospital of Emergency Care - Infarction
🇺🇦Kyiv, Ukraine
Clinical Hosp on the railway line №2 branch PHC JSC Ukrzaliz
🇺🇦Kyiv, Ukraine
MD Strazheska Institute of Cardiology of NAMSU - Resuscitati
🇺🇦Kyiv, Ukraine
Kyiv Regional Hospital
🇺🇦Kyiv, Ukraine
City Clinical Emergency Hospital - Cardiology department
🇺🇦Lviv, Ukraine
Odesa Regional Clinical Hospital
🇺🇦Odesa, Ukraine
Odessa Clinical Railway Hospital - Outpatient department
🇺🇦Odesa, Ukraine
City Clinical Hospital #1 - Therapy department
🇺🇦Vinnytsia, Ukraine
Vinnytsia Regional Clinical Hospital - Cardiology department
🇺🇦Vinnytsia, Ukraine
Central City Hospital #1 - Scientific-Research center
🇺🇦Zhytomyr, Ukraine
Zhytomir Regional Clinical Hospital - Cardio-Arrhytm. centre
🇺🇦Zhytomyr, Ukraine
Harrogate District Hospital
🇬🇧Harrogate, North Yorkshire, United Kingdom
Clifton Medical Centre
🇬🇧Rotherham, South Yorkshire, United Kingdom
St. Richards Hospital
🇬🇧Chichester, West Sussex, United Kingdom
Crouch Oak Family Practice
🇬🇧Addlestone, United Kingdom
Stroke Trials Office
🇬🇧Airdrie, United Kingdom
Antrim Area Hospital
🇬🇧Antrim, United Kingdom
Axbridge & Wedmore Medical Practice
🇬🇧Axbridge, United Kingdom
Bermuda Practice
🇬🇧Basingstoke, United Kingdom
Sea Road Surgery
🇬🇧Bexhill-on-Sea, United Kingdom
Birmingham Heartlands Hospital
🇬🇧Birmingham, United Kingdom
Layton Medical Centre
🇬🇧Blackpool, United Kingdom
Bollington Medical Centre
🇬🇧Bollington, United Kingdom
The Health Centre
🇬🇧Bradford-on-Avon, United Kingdom
Southmead Hospital
🇬🇧Bristol, United Kingdom
Ely Bridge Surgery
🇬🇧Cardiff, United Kingdom
St Peters Hospital, Chertsey
🇬🇧Chertsey, United Kingdom
Countess Of Chester NHS Foundation Trust
🇬🇧Chester, United Kingdom
WISDEM Centre
🇬🇧Coventry, United Kingdom
Ninewells Hospital
🇬🇧Dundee, United Kingdom
Royal Devon University Healthcare NHS Foundation Trust
🇬🇧Exeter, United Kingdom
Department Of Cardiac Research
🇬🇧Harrow, United Kingdom
Wycombe General Hospital
🇬🇧High Wycombe, United Kingdom
Hull Royal Infirmary
🇬🇧Hull, United Kingdom
Cardiology
🇬🇧Leicester, United Kingdom
Guys Hospital
🇬🇧London, United Kingdom
Kings College Hospital
🇬🇧London, United Kingdom
Imperial College London
🇬🇧London, United Kingdom
Lincoln County Hospital
🇬🇧Lincoln, United Kingdom
University Hospital Aintree
🇬🇧Liverpool, United Kingdom
Diabetes Centre North Manchester General Hospital
🇬🇧Manchester, United Kingdom
Cardio Research
🇬🇧Middlesbrough, United Kingdom
University Dept of Medicine, Derriford Hospital, Plymouth
🇬🇧Plymouth, United Kingdom
Clarence Medical Centre
🇬🇧Rhyl, United Kingdom
Ashfields Primary Care Centre
🇬🇧Sandbach, United Kingdom
Clinical Research Unit
🇬🇧Somerset, United Kingdom
Moorgreen Hospital
🇬🇧Southampton, United Kingdom
Lister Hospital
🇬🇧Stevenage, United Kingdom
Sunderland Royal Hospital
🇬🇧Sunderland, United Kingdom
Musgrove Park Hospital
🇬🇧Taunton, United Kingdom
Cardiology Department
🇬🇧Torquay, United Kingdom
Royal Cornwall Hospital (Treliske)
🇬🇧Truro, United Kingdom
University Hospital Wishaw
🇬🇧Wishaw, United Kingdom
University of Colorado Hospital
🇺🇸Aurora, Colorado, United States
Yale University School Of Medicine
🇺🇸New Haven, Connecticut, United States
AdventHealth Diab Inst
🇺🇸Orlando, Florida, United States
Robley Rex VA Medical Center
🇺🇸Louisville, Kentucky, United States
L-MARC Research Center
🇺🇸Louisville, Kentucky, United States
Norton Clinical Research Group
🇺🇸Louisville, Kentucky, United States
Michigan Medicine
🇺🇸Ann Arbor, Michigan, United States
Medical Uni of SC Charleston
🇺🇸Charleston, South Carolina, United States
NSC Research, Inc
🇺🇸Johns Creek, Georgia, United States
Long Beach VA healthcare System
🇺🇸Long Beach, California, United States
Optumcare Colorado Springs
🇺🇸Colorado Springs, Colorado, United States
MD Medical Research
🇺🇸Oxon Hill, Maryland, United States
Bradenton Research Center
🇺🇸Bradenton, Florida, United States
Florida Premier Cardiology
🇺🇸Delray Beach, Florida, United States
Advanced Med Res Maumee
🇺🇸Maumee, Ohio, United States
Sentara Medical Group_Norfolk
🇺🇸Virginia Beach, Virginia, United States
Duke University - S.E Cardio
🇺🇸Lumberton, North Carolina, United States
Confluence Health Hospital
🇺🇸Wenatchee, Washington, United States
AngioCor Blumenau
🇧🇷Blumenau, Santa Catarina, Brazil
Lokmanya Tilak Municipal Medical College & General Hospital
🇮🇳Mumbai, Maharashtra, India
Tickerdoc Research (Pty) LTD
🇿🇦Johannesburg, Gauteng, South Africa
Aspirus Research Institute
🇺🇸Wausau, Wisconsin, United States
Royal Adelaide Hospital Cardiovascular Clinical Trials
🇦🇺Adelaide, South Australia, Australia
G.A. Research Associates Ltd.
🇨🇦Moncton, New Brunswick, Canada
Unidad Biomedica Avanzada Monterrey
🇲🇽Monterrey, Nuevo León, Mexico
Clin. Centre Vojvodina, Clin. endocr., diab. and met. dis.
🇷🇸Novi Sad, Vojvodina, Serbia
WITS Clinical Research
🇿🇦Johannesburg, Gauteng, South Africa
UCT Lung institute
🇿🇦Cape Town, Western Cape, South Africa
Dr. Alexander Perkelvald
🇺🇸Brooklyn, New York, United States
St. Vincent Hosp-Prevea Health
🇺🇸Green Bay, Wisconsin, United States
Hospital Ramón y Cajal
🇪🇸Madrid, Spain
Hospital Universitario La Paz
🇪🇸Madrid, Spain
Southgate Medical Group, LLP
🇺🇸West Seneca, New York, United States
Integrative Research Assoc Inc
🇺🇸Fort Lauderdale, Florida, United States
UNC Eastowne Clinical Trials Unit
🇺🇸Chapel Hill, North Carolina, United States
Texas Diab & Endo, P.A.
🇺🇸Austin, Texas, United States
Dominion Medical Associates
🇺🇸Richmond, Virginia, United States
Clinical Research Partners, LLC
🇺🇸Richmond, Virginia, United States
National Clin Res Inc.
🇺🇸Richmond, Virginia, United States
G Kuppuswamy Naidu Memorial Hospital
🇮🇳Coimbatore, Tamil Nadu, India
Clinical Neuroscience Solutions, Inc.
🇺🇸Jacksonville, Florida, United States
The Stern Cardiovascular Group
🇺🇸Germantown, Tennessee, United States
Mater Miscericordiae Hospital
🇮🇪Dublin, Leinster, Ireland
Cardiology Clinical Research
🇿🇦Alberton, Gauteng, South Africa
Grant Medical Foundation
🇮🇳Pune, Maharashtra, India